Titan Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
TTNP
US8883141017
Pharmaceuticals
Sales 2022 | 557K 761K | Sales 2023 | 184K 252K | Capitalization | 6.21M 8.5M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.67M | Net income 2023 | -5M -6.84M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M 3.76M | Net cash position 2023 | 6.2M 8.47M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 22-08-14 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 23-10-11 |
Brynner Chiam
BRD | Director/Board Member | - | 23-10-11 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |